RKDAArcadia Biosciences, Inc.vs its industry peers
A metric-by-metric comparison of Arcadia Biosciences, Inc. against SIC 1311 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RKDAThis | $361382#7 | — | 0.1x#1 | 0.1x#1 | -3.7%#5 | 66.8%#5 | -51.5%#8 | -37.6%#8 | — | — | -95.9%#1 | — |
| CKX | $22M#1 | 7.5x#3 | 1.0x#6 | 26.0x#7 | -44.9%#12 | 1102.9%#1 | 434.2%#1 | 13.9%#1 | — | — | — | — |
| MXC | $20M#2 | 13.3x#5 | 1.0x#5 | 3.1x#4 | -8.1%#7 | -23.7%#10 | 19.4%#3 | 6.4%#2 | 4.9%#1 | — | — | 1.0%#1 |
| EONR | $16M#3 | — | 0.3x#3 | 0.9x#3 | -12.8%#9 | 8.2%#9 | -60.6%#9 | -15.4%#6 | -17.5%#4 | — | — | — |
| BRN | $13M#4 | — | 1.4x#7 | 0.9x#2 | -24.2%#11 | -27.6%#11 | 0.2%#6 | -80.1%#9 | — | — | — | — |
| TPET | $9M#5 | 0.4x#1 | 0.2x#2 | 22.4x#6 | 87.0%#3 | 24.4%#7 | -1322.2%#12 | -20.0%#7 | -36.1%#5 | — | — | — |
| GBR | $3M#6 | — | 0.7x#4 | 20.9x#5 | 6.2%#4 | -155.6%#13 | -171.0%#11 | -1.0%#4 | -6.2%#3 | — | — | — |
| ALTX | — | — | — | — | -21.7%#10 | -143.9%#12 | — | -14.9%#5 | — | — | — | — |
| ANNA | — | 12.5x#4 | — | — | 1663.0%#1 | 123.2%#2 | 11.6%#4 | — | — | — | — | — |
| ANNAW | — | 1.2x#2 | — | — | 1663.0%#1 | 123.2%#2 | 11.6%#4 | — | — | — | — | — |
| APHD | — | — | — | — | -100.0%#14 | 45.9%#6 | — | -1565.5%#10 | — | — | — | — |
| BDCO | — | — | — | — | -12.0%#8 | — | -0.5%#7 | 0.0%#3 | -4.4%#2 | — | — | — |
| BSM | — | — | — | — | -3.9%#6 | 10.5%#8 | 73.0%#2 | — | — | — | — | — |
| CEIN | — | — | — | — | -78.2%#13 | 93.5%#4 | -127.6%#10 | — | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 1311). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice